ACCORD GLYCERYL TRINITRATE SUBLINGUAL SPRAY 400MCG
Accord Glyceryl Trinitrate (GTN) Sublingual Spray 400 micrograms is a prescription-category medicine supplied as a metered sublingual spray. Please read the patient leaflet and speak to our pharmacist before use.
₦15,000.00
2 in stock
Add to wishlist Add to compareAsk about productDescription
Accord Glyceryl Trinitrate Sublingual Spray 400mcg is a glyceryl trinitrate (GTN) spray made by Accord. It is supplied as a metered spray for sublingual use (under the tongue). It is listed in our prescription medicines category.
Product details
- Product: Accord Glyceryl Trinitrate Sublingual Spray
- Active ingredient: Glyceryl trinitrate (GTN)
- Strength: 400 micrograms per metered dose
- Form: Sublingual spray
- Manufacturer: Accord
Important information
This medicine should only be used as directed by your doctor. Always read the patient information leaflet supplied with the product, and speak to our pharmacist if you have any questions about whether this medicine is suitable for you.
Storage
Store as directed on the pack and in the leaflet. Keep out of the sight and reach of children.
Buy with confidence
Bonamour Pharmacy supplies genuine medicines sourced through approved channels. Our pharmacists are happy to advise before you order.
Frequently asked questions
Do I need a prescription for this spray?
This product is listed in our prescription medicines category. Our pharmacist may ask for a valid prescription or further details before supplying it.
How should I store Accord GTN Sublingual Spray?
Store it as directed on the pack and in the patient leaflet, and keep it out of the sight and reach of children.
Is this product genuine?
Yes. Bonamour Pharmacy sources its medicines through approved suppliers, and this spray is the Accord brand.
Can I have it delivered or collect it in store?
You can choose delivery or pickup at checkout, subject to availability and any checks our pharmacist needs to carry out.
You must be logged in to post a review.
Reviews
There are no reviews yet.